Anti-Migraine Therapies 2005 B2B Conferences
Attend the visiongain's b2b conference, ANTI-MIGRAINE THERAPIES 2005: IMPROVING DISEASE UNDERSTANDING, DRUG DELIVERY AND FUTURE TARGETS. This conference's objective is to provide a unique forum to discuss the new developments in significant areas of the anti-migraine therapies market. This includes new research data to innovations in drug delivery to future targets for drugs.
PR9.NET December 03, 2004 - London, UK; – Attend the visiongain's b2b conference, ANTI-MIGRAINE THERAPIES 2005: IMPROVING DISEASE UNDERSTANDING, DRUG DELIVERY AND FUTURE TARGETS. This conference's objective is to provide a unique forum to discuss the new developments in significant areas of the anti-migraine therapies market. This includes new research data to innovations in drug delivery to future targets for drugs.
Migraine is the most common neurological condition in the developed world. In the seven major pharmaceutical markets, (US, France, Germany, Italy, Spain, UK and Japan) migraine afflicted more than 74 million people in 2002. It affects 11% of the UK population and is more prevalent than diabetes, epilepsy and asthma combined.
Over the two days, this event will provide a comprehensive focus on the potential for genetic research in the future of migraine treatments and discovery the possibilities for new drugs. Leaders from the Pharmaceutical sector will also investigate the main challenges involved in alternative therapies and the new possibilities for Botox as an anti-migraine treatment. Learn directly from the experts: focused and detailed case studies from industry leaders GSK, Boehringer-Ingelheim; Aradigm. Additional, discover the possible future targets for anti-migraine therapies and learn which are the areas to watch: ensure your company gains its share of the market and the benefit from the new technology available and achieve more efficient drug delivery for your drugs
The ANTI-MIGRAINE THERAPIES CONFERENCE will take place on March 8th & 9th at the Hilton Kensington Hotel, London.
Companies and organisations participating in the conference program:
Dr. Michael James, Head of Preclinical MRI, Neurology & Gastrointestinal CEDD , GlaxoSmithKline
Dr. Henry Doods, Head of Pain Research, Boehringer-Ingelheim
Dr. Stephen Farr, Chief Scientific Officer, Aradigm
Dr. Chas Bountra, Head, Pain Research, GlaxoSmithKline
Barry Cohen, Vice President & New Product Development, NovaDel
Dr. Stephen Silberstein, Director, Jefferson Headache Center
Dr. Don Penzien, Director & Founder, UMC Head Pain Center
Dr. Ann Pakalnis, Clinical Associate Professor of Paediatrics & Neurology, Ohio State University & Columbus Children's Hospital
Complementing this conference, is a Pre-conference Interactive Workshop (Thursday 7th March 2005) entitled PRICING AND POSITIONING FOR AN INNOVATIVE ANTI-MIGRAINE TREATMENT which will be led by:
Mr. Christian Schuler, Director, Health Sciences Division, Simon-Kucher & Partners
This pre-conference workshop focuses on pricing and reimbursement environment in the anti-migraine market and value based pricing for a new anti-migraine treatment. With an in-depth analysis of the ideal positioning of an innovative anti-migraine therapy and how to derive optimal prices.
For more information about this event, please visit www.b2b-conferences.com
# # #
B2B Conferences is one of Europe's fastest growing media companies today, basing its knowledge on the raft of management reports and industry news letter that the parent company produces each year. B2B Conferences has built up a solid reputation for putting together high quality business to business event workshops aimed at the corporate community.
These events are unique in that B2B operates on a wholly independent basis, therefore producing conferences that are timely, targeted and at time controversial, giving delegates, speakers and sponsors alike, the opportunity to get a totally unbiased view of their industry.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe today. visiongain produce a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Financial markets, the Pharmaceutical, Telecoms industries and the Defence sector.
|Recent News Headlines
|Industry Category of Current Press Release